Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB), International Journal of Antimicrobial Agents, May 2009, Elsevier,
DOI: 10.1016/j.ijantimicag.2008.10.028.
You can read the full text:
Contributors
The following have contributed to this page